Navigation Links
Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes
Date:5/5/2009

p>

Through a long-standing commitment to diabetes care, Lilly provides patients with breakthrough treatments that enable them to live longer, healthier and fuller lives. Since 1923, Lilly has been the industry leader in pioneering therapies to help healthcare professionals improve the lives of people with diabetes, and research continues on innovative medicines to address the unmet needs of patients.

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Indiana, Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs.

Alkermes, Inc. is a fully integrated biotechnology company committed to developing innovative medicines to improve patients' lives. Alkermes' robust pipeline includes extended-release injectable, pulmonary and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Cambridge, Massachusetts, Alkermes has research facilities in Massachusetts and a commercial manufacturing facility in Ohio.

This press release contains forward-looking statements about Amylin, Lilly and Alkermes and the investigational drug, exenatide once weekly. Actual results could differ materially from those discussed or implied in this press release due to a number of risks and uncertainties, including the risk that BYETTA and/or the approval of exenatide once weekly and the revenues generated from BYETTA and/or exenatide once weekly may be affected by competition; unexpected new data; safety and technical issues; pre-clinical trial results; clinical trials, including the clinical trials mentioned in this press release, not being
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. New Data From Head-to-Head Phase 3 Trial Demonstrate That Liraglutide is More Effective Than Exenatide in Treatment of Type 2 Diabetes
2. Lilly and Amylin Enter Into Supply Agreement for Exenatide Once Weekly
3. Exenatide Clinical Data Analysis Shows No Increased Risk of Cardiovascular Events
4. European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreichs Ataxia by Santhera
5. Barr Confirms Filing an Application With a Paragraph IV Certification for Femcon(R) FE Chewable Oral Contraceptive Product
6. KineMed to Collaborate With Merck KgaA to Validate New Applications for Drug Development Candidates
7. MichBio Announces Expo Tours; Extends Deadline for Innovator Showcase Applications
8. FDA Accepts ISO-Vorin(TM) New Drug Application Amendment Submitted by Spectrum Pharmaceuticals
9. Isis Announces $4.2 Million in Government Contracts Awarded to Its Ibis Subsidiary for Biodefense Applications Development
10. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
11. Nitecs IND Application for Clinical Development With Lodotra Accepted by the FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... This is a professional and in-depth ... (IPA) industry. The report provides a basic overview ... chain structure. Global market analysis and Chinese domestic ... history, developments, trends and competitive landscape of the ... situation is also offered. , The report ...
(Date:9/23/2014)... Marktech Optoelectronics has introduced the MTE280xxx series, its ... 280 nm wavelength range. This series joins Marktech’s current ... to 405nm. These new devices are suitable for applications ... Mark Campito, Marktech’s CEO states that “what makes this ... that we offer it in one of the largest ...
(Date:9/22/2014)... treated with a statin in the hospital after suffering ... survive than those who were not, according to a ... study was conducted by the same researchers who recently ... survival in victims of ischemic stroke., Ischemic stroke is ... vessel that blocks blood from reaching areas of the ...
(Date:9/22/2014)... cell fragments whose job it is to stop bleeding, ... But they can "feel" the physical environment around them, ... Platelets respond to surfaces with greater stiffness by increasing ... other platelets and other components of the clotting system, ... give them credit for, in that they are able ...
Breaking Biology Technology:(IPA) Isopropanol Industry International & China Development Trend Analysis Now Available at DeepResearchReports.com 2(IPA) Isopropanol Industry International & China Development Trend Analysis Now Available at DeepResearchReports.com 3Marktech Introduces its New Line of Deep UV Emitters 2Statin use during hospitalization for hemorrhagic stroke associated with improved survival 2Platelets modulate clotting behavior by 'feeling' their surroundings 2
... NIOX MINO(R) Set to Dramatically Improve Airway Inflammatory Disease ... Management through Personalized Inflammation Control, NEW PROVIDENCE, N.J., ... that NIOX MINO (http://www.nioxmino.com ), a,hand- held point-of-care ... cleared by the U.S. Food and Drug Administration (FDA).,Physicians ...
... RICHMOND, Va., March 4 Insmed Inc. (Nasdaq,CM: INSM), a developer of ... December 31, 2007., Full-Year 2007 and Recent Company Highlights, ... Completed development of INS-19 (Granulocyte Colony Stimulating ... these products to ...
... First Joint U.S. National Modeling and ... Simulation Meeting on March 11-12, 2008, ... PHST ), a leading provider of software, strategic,consulting, ... its broad-based participation at the inaugural,meeting of the American ...
Cached Biology Technology:FDA Grants Market Clearance to Aerocrine Inc.'s NIOX MINO(R): a New Hand-Held Device to Measure Airway Inflammation in Asthma 2FDA Grants Market Clearance to Aerocrine Inc.'s NIOX MINO(R): a New Hand-Held Device to Measure Airway Inflammation in Asthma 3FDA Grants Market Clearance to Aerocrine Inc.'s NIOX MINO(R): a New Hand-Held Device to Measure Airway Inflammation in Asthma 4Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results 2Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results 3Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results 4Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results 5Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results 6Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results 7Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results 8Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results 9Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results 10Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results 11Pharsight Makes Strong Contribution to Inaugural American Conference on Pharmacometrics 2Pharsight Makes Strong Contribution to Inaugural American Conference on Pharmacometrics 3
(Date:9/23/2014)... or isoforms in microRNAs (miRNAs) before, but assumed that ... in the journal Oncotarget this month, shows ... on geographic subpopulations and gender and that the most ... the one typically listed in the public databases. , ... common than we had previously assumed. The fact that ...
(Date:9/23/2014)... When the body forms new tissues during the ... with each other. For years, scientists believed this ... at Carnegie Mellon University and the University of ... communication is equally if not more crucial. ... the Proceedings of the National Academy of ...
(Date:9/23/2014)... Research by Rice University scientists who are fighting a ... be a clinician,s most powerful ally. , "Recent research ... cyberwarfare against the immune system, and we studied the ... how we might turn the tables on cancer," said ... this week in the Early Edition of the ...
Breaking Biology News(10 mins):Slight alterations in microRNA sequences hold more information than previously thought 2Slight alterations in microRNA sequences hold more information than previously thought 3The mechanics of tissue growth 2Immune system is key ally in cyberwar against cancer 2Immune system is key ally in cyberwar against cancer 3
... single female is nearby, female antbirds will sing over the ... keep their messages from getting through, according to a new ... , a Cell Press publication. Males respond to that interruption ... first evidence that such "signal jamming" and "jamming avoidance" occur ...
... at Birmingham professor Lisa Guay-Woodford, M.D., will receive ... Jean Kaplan International Prize for Advancement in the ... The PKD Foundation and the International Society of ... contributions to the field of polycystic kidney disease ...
... of who will carry the burden but could instead ... economic modeling presented today at "Climate Change: Global Risks, ... Contrary to current cost models for lowering ... of researchers from the University of Cambridge conclude that ...
Cached Biology News:Female birds 'jam' their mates' flirtatious songs 2UAB's Lisa Guay-Woodford earns top international nephrology prize 2UAB's Lisa Guay-Woodford earns top international nephrology prize 3Fighting global warming offers growth and development opportunities 2Fighting global warming offers growth and development opportunities 3
The novel and unique HCTplus delivers unmatched information-rich data-dependent LC/MSn data for todays challenge in proteomics and metabonomics work....
... new chapter to a 40-year ... 7890A GC gives you everything ... lab to the next level ... including advanced separation capabilities, powerful ...
... the six short years since publication of ... Walkers widely acclaimed Protein Protocols Handbook, there ... protein biochemistry. In recognition of the level ... rapid evolution of new methodologies directed to ...
... often call for critical, but time-consuming ... refines siRNA transfection protocols resulting in ... can be used to efficiently transfect ... without increased cytotoxicity. From start ...
Biology Products: